Nj State Employees Deferred Compensation Plan Madrigal Pharmaceuticals, Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $877 Million
- Q3 2025
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 1,500 shares of MDGL stock, worth $732,870. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$732,870
Previous $453,000
51.66%
% of portfolio
0.08%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
371Shares Held
23.2MCall Options Held
738KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$1.07 Billion0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$1.02 Billion32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$974 Million9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$965 Million6.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.88MShares$916 Million10.35% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $8.36B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...